
Mumps Vaccine (MumpsVax) Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts
Description
Mumps Vaccine (MumpsVax) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on mumps vaccine (mumpsvax) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Where is the largest and fastest growing market for mumps vaccine (mumpsvax) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The mumps vaccine (mumpsvax) market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Markets Covered:1) By Product Type: Monovalent; Combinational; Divalent; Trivalent; Other Product Types
2) By Age Group: Pediatric; Adult
3) By Distribution Channels: Hospital pharmacies; Drug Stores; Retail Pharmacies
4) By End-User: Pediatric Clinic; Hospitals; Non-Governmental Organization (NGOs); Other End-Users
Companies Mentioned: Merck & Co. Inc.; GlaxoSmithKline plc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
This report focuses on mumps vaccine (mumpsvax) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 10 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 3-4 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for mumps vaccine (mumpsvax) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The mumps vaccine (mumpsvax) market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered:1) By Product Type: Monovalent; Combinational; Divalent; Trivalent; Other Product Types
2) By Age Group: Pediatric; Adult
3) By Distribution Channels: Hospital pharmacies; Drug Stores; Retail Pharmacies
4) By End-User: Pediatric Clinic; Hospitals; Non-Governmental Organization (NGOs); Other End-Users
Companies Mentioned: Merck & Co. Inc.; GlaxoSmithKline plc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Table of Contents
175 Pages
- 1. Executive Summary
- 2. Mumps Vaccine (MumpsVax) Market Characteristics
- 3. Mumps Vaccine (MumpsVax) Market Biologic Drug Characteristics
- 3.1. Molecule Type
- 3.2. Route Of Administration (ROA)
- 3.3. Mechanism Of Action (MOA)
- 3.4. Safety And Efficacy
- 4. Mumps Vaccine (MumpsVax) Market Trends And Strategies
- 5. Mumps Vaccine (MumpsVax) Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
- 6. Global Mumps Vaccine (MumpsVax) Growth Analysis And Strategic Analysis Framework
- 6.1. Global Mumps Vaccine (MumpsVax) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 6.2. Analysis Of End Use Industries
- 6.3. Global Mumps Vaccine (MumpsVax) Market Growth Rate Analysis
- 6.4. Global Mumps Vaccine (MumpsVax) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 6.5. Global Mumps Vaccine (MumpsVax) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 6.6. Global Mumps Vaccine (MumpsVax) Total Addressable Market (TAM)
- 7. Global Mumps Vaccine (MumpsVax) Market Pricing Analysis & Forecasts
- 8. Mumps Vaccine (MumpsVax) Market Segmentation
- 8.1. Global Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Monovalent
- Combinational
- Divalent
- Trivalent
- Other Product Types
- 8.2. Global Mumps Vaccine (MumpsVax) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Pediatric
- Adult
- 8.3. Global Mumps Vaccine (MumpsVax) Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals Pharmacies
- Drug Stores
- Retail Pharmacies
- 8.4. Global Mumps Vaccine (MumpsVax) Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Pediatric Clinic
- Hospitals
- Non-Governmental Organization (NGOs)
- Other End-Users
- 9. Global Mumps Vaccine (MumpsVax) Market Epidemiology Of Clinical Indications
- 9.1. Drug Side Effects
- 9.2. Incidence And Prevalence of Clinical Indications
- 10. Mumps Vaccine (MumpsVax) Market Regional And Country Analysis
- 10.1. Global Mumps Vaccine (MumpsVax) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. Global Mumps Vaccine (MumpsVax) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11. Asia-Pacific Mumps Vaccine (MumpsVax) Market
- 11.1. Asia-Pacific Mumps Vaccine (MumpsVax) Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 11.2. Asia-Pacific Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Asia-Pacific Mumps Vaccine (MumpsVax) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Asia-Pacific Mumps Vaccine (MumpsVax) Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12. China Mumps Vaccine (MumpsVax) Market
- 12.1. China Mumps Vaccine (MumpsVax) Market Overview
- 12.2. China Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 12.3. China Mumps Vaccine (MumpsVax) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 12.4. China Mumps Vaccine (MumpsVax) Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 13. India Mumps Vaccine (MumpsVax) Market
- 13.1. India Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. India Mumps Vaccine (MumpsVax) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. India Mumps Vaccine (MumpsVax) Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14. Japan Mumps Vaccine (MumpsVax) Market
- 14.1. Japan Mumps Vaccine (MumpsVax) Market Overview
- 14.2. Japan Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. Japan Mumps Vaccine (MumpsVax) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. Japan Mumps Vaccine (MumpsVax) Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15. Australia Mumps Vaccine (MumpsVax) Market
- 15.1. Australia Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.2. Australia Mumps Vaccine (MumpsVax) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Australia Mumps Vaccine (MumpsVax) Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16. South Korea Mumps Vaccine (MumpsVax) Market
- 16.1. South Korea Mumps Vaccine (MumpsVax) Market Overview
- 16.2. South Korea Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. South Korea Mumps Vaccine (MumpsVax) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.4. South Korea Mumps Vaccine (MumpsVax) Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17. Western Europe Mumps Vaccine (MumpsVax) Market
- 17.1. Western Europe Mumps Vaccine (MumpsVax) Market Overview
- 17.2. Western Europe Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Western Europe Mumps Vaccine (MumpsVax) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.4. Western Europe Mumps Vaccine (MumpsVax) Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18. UK Mumps Vaccine (MumpsVax) Market
- 18.1. UK Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. UK Mumps Vaccine (MumpsVax) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. UK Mumps Vaccine (MumpsVax) Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19. Germany Mumps Vaccine (MumpsVax) Market
- 19.1. Germany Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Germany Mumps Vaccine (MumpsVax) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Germany Mumps Vaccine (MumpsVax) Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20. France Mumps Vaccine (MumpsVax) Market
- 20.1. France Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. France Mumps Vaccine (MumpsVax) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. France Mumps Vaccine (MumpsVax) Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21. Eastern Europe Mumps Vaccine (MumpsVax) Market
- 21.1. Eastern Europe Mumps Vaccine (MumpsVax) Market Overview
- 21.2. Eastern Europe Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Mumps Vaccine (MumpsVax) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Mumps Vaccine (MumpsVax) Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22. North America Mumps Vaccine (MumpsVax) Market
- 22.1. North America Mumps Vaccine (MumpsVax) Market Overview
- 22.2. North America Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. North America Mumps Vaccine (MumpsVax) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.4. North America Mumps Vaccine (MumpsVax) Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23. USA Mumps Vaccine (MumpsVax) Market
- 23.1. USA Mumps Vaccine (MumpsVax) Market Overview
- 23.2. USA Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. USA Mumps Vaccine (MumpsVax) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. USA Mumps Vaccine (MumpsVax) Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24. Canada Mumps Vaccine (MumpsVax) Market
- 24.1. Canada Mumps Vaccine (MumpsVax) Market Overview
- 24.2. Canada Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. Canada Mumps Vaccine (MumpsVax) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. Canada Mumps Vaccine (MumpsVax) Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25. South America Mumps Vaccine (MumpsVax) Market
- 25.1. South America Mumps Vaccine (MumpsVax) Market Overview
- 25.2. South America Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. South America Mumps Vaccine (MumpsVax) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. South America Mumps Vaccine (MumpsVax) Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26. Middle East Mumps Vaccine (MumpsVax) Market
- 26.1. Middle East Mumps Vaccine (MumpsVax) Market Overview
- 26.2. Middle East Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. Middle East Mumps Vaccine (MumpsVax) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. Middle East Mumps Vaccine (MumpsVax) Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27. Africa Mumps Vaccine (MumpsVax) Market
- 27.1. Africa Mumps Vaccine (MumpsVax) Market Overview
- 27.2. Africa Mumps Vaccine (MumpsVax) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Africa Mumps Vaccine (MumpsVax) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.4. Africa Mumps Vaccine (MumpsVax) Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28. Mumps Vaccine (MumpsVax) Market Competitive Landscape And Company Profiles
- 28.1. Mumps Vaccine (MumpsVax) Market Competitive Landscape
- 28.2. Mumps Vaccine (MumpsVax) Market Company Profiles
- 28.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 28.2.2. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
- 28.2.3. Sinovac Biotech Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 28.2.4. Serum Institute of India Pvt. Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 28.2.5. Shaurya International Overview, Products and Services, Strategy and Financial Analysis
- 29. Global Mumps Vaccine (MumpsVax) Market Pipeline Analysis
- 29.1. High Level Clinic Trail Information
- 30. Global Mumps Vaccine (MumpsVax) Market Competitive Benchmarking And Dashboard
- 31. Key Mergers And Acquisitions In The Mumps Vaccine (MumpsVax) Market
- 32. Recent Developments In The Mumps Vaccine (MumpsVax) Market
- 33. Mumps Vaccine (MumpsVax) Market High Potential Countries, Segments and Strategies
- 33.1 Mumps Vaccine (MumpsVax) Market In 2029 - Countries Offering Most New Opportunities
- 33.2 Mumps Vaccine (MumpsVax) Market In 2029 - Segments Offering Most New Opportunities
- 33.3 Mumps Vaccine (MumpsVax) Market In 2029 - Growth Strategies
- 33.3.1 Market Trend Based Strategies
- 33.3.2 Competitor Strategies
- 34. Appendix
- 34.1. Abbreviations
- 34.2. Currencies
- 34.3. Historic And Forecast Inflation Rates
- 34.4. Research Inquiries
- 34.5. The Business Research Company
- 34.6. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.